Rare sugars like D-allulose, D-tagatose, and D-sorbose significantly boosted GLP-1 secretion and suppressed food intake in ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

As obesity rates rise in India and GLP-1 drugs gain traction despite cost and safety concerns, Mumbai-based gut health ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

OB-GYNs explain how they're using semaglutide and tirzepatide to treat symptoms of PCOS. The meds help treat weight gain, ...

Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

Around 5 million American women have PCOS, which plays into weight, reproductive health, and fertility outcomes. Here's possible new help.

The drugs are not approved for use in people with type 1 diabetes MONDAY, March 31, 2025 (HealthDay News) -- Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased ...

Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G ...